LISA SCHMIDT: Open Payments
NPI 1356433429 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 48 payments from 10 companies in 2025. Trend: 2023 $1,825 · 2024 $1,482 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $247 |
| Alkermes, Inc. | 5 | $200 |
| Supernus Pharmaceuticals, Inc. | 10 | $180 |
| Axsome Therapeutics, Inc. | 3 | $160 |
| Corium, LLC | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Noven Therapeutics, LLC | 1 | $23 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Qelbree, VIVITROL, Auvelity, ARISTADA, Azstarys, Sunosi.
Industry payments across FL — which companies pay providers there.
